Purpose: To measure association between paroxysmal events and length of monitoring to identify a practicable duration time for capturing seizures in the elderly. Methods: Consecutive inpatients 60 years and older who were admitted to the Epilepsy Center and underwent prolonged video electroencephalogram (VEEG) monitoring (VEM) were reviewed retrospectively. Electronic medical records were reviewed to collect information regarding sex, age at onset of symptoms and examination, concurrent epilepsy, frequency of seizures, diagnosis before and after examination, antiepileptic drugs (AEDs), brain magnetic resonance imaging (MRI), and VEEG findings. Results: A total of 184 consecutive elderly inpatients were enrolled. The mean age was 67.1 AE 6.1 years (range, 60-89 years), with 69 females and 115 males. Mean length of monitoring was 20.4 AE 18.9 h (range, 1 h-6 days). During LTM, 89 patients (48.4%) recorded paroxysmal events, including 58 epileptic seizures (43.3%) and 31 non-epileptic events (16.8%). All non-epileptic events were captured during the first 24 h. All first epileptic events were detected during the first 4 days, with 98.9% of them recorded by the end of the 2nd day. Increased seizure incidence (p = 0.000, odd ratio [OR] = 0.075, 95% confidence interval [95% CI]: 0.035-0.163) and length of monitoring (p = 0.001, OR = 1.044, 95%CI: 1.017-1.071) were independently associated with paroxysmal events capture. Conclusions: It may be practicable to monitor for 24 h when a non-epileptic seizure is suspected, with expected monitoring duration of 2 days when an epileptic seizure with daily or persistent frequency is considered, except for pre-surgical evaluations.
Introduction
Video electroencephalogram (VEEG) monitoring is regarded as the gold standard diagnostic tool for diagnosing seizure disorders, classifying seizure types, and evaluating surgical candidates with intractable epilepsy [1] [2] [3] [4] . Further, inpatient prolonged VEEG monitoring (VEM) is a widely used diagnostic tool for seizures and other paroxysmal behavioral events [5] [6] [7] . Accordingly, VEM typically ranges from 1 h to 24 h, but can be prolonged for several days or weeks when necessary. Moreover, VEM is an established investigation for adult and pediatric patients with paroxysmal clinical events, raising the diagnostic possibility of epilepsy [8, 9] . Epilepsy is frequent in the elderly, with an estimated prevalence of 1-2% in people over the age of 60, and 7.7% in institutionalized patients over 65 [10, 11] . Elderly patients can have episodes that mimic seizures but may be the result of syncope, a sleep disorder, or psychiatric illness [12] .
Few studies have focused on the optimal time of VEM for capturing seizures, with the study subjects being adult patients with a mean age of around 30 or 40 years [13] [14] [15] [16] . Consequently, the appropriate length of monitoring for detecting paroxysmal events in old patients is still unknown. Considering the high-cost and time-consuming characteristics of VEM, the aim of this study was to measure association between paroxysmal events and length of monitoring to identify a practicable and economical duration time for capturing paroxysmal events in the elderly.
Methods

Study setting and subjects
This study was conducted in the epilepsy monitoring unit (EMU) in Peking Union Medical College Hospital (PUMCH), a tertiary hospital in Beijing, China. Patients came from all over China and got admitted for VEM only after an epilepsy clinic visit or referred by a general neurologist in charge of the Neurology ward. The center was founded in 2008 and had four EMU beds. Over 4300 patients have undergone VEM so far. Consecutive inpatients 60 years and older who were admitted and underwent VEM between January 2008 and December 2016 were reviewed retrospectively. Electronic medical records were reviewed to collect information regarding sex, age at onset of symptoms and examination, concurrent epilepsy, frequency of seizures, diagnosis before and after examination, antiepileptic drugs (AEDs), brain magnetic resonance imaging (MRI), and VEEG findings. Scalp electrodes were placed according to the International 10-20 System. Digital VEEG recordings were obtained using a 19 digital EEG system. Constant patient surveillance during VEM was performed by an EEG technologist or nursing staff well-experienced in response testing and acute seizure management.
Seizure frequency was classified as daily (one or more seizures per day), persistent (less than one seizure per day but at least one seizure in the last six months), rare (less than one seizure per six months), or undefined (seizure frequency cannot be specified because of recent epilepsy onset) [17] .
Measures
A trained EEG technician and epileptologist independently reviewed all VEEG data and marked specific events. Special attention was given to the onset of events recorded by the patients or caregivers. Two of the authors (XQ Zhou and HY Sun) independently reviewed interictal and ictal VEEG. All identified events were condensed and further reviewed independently by two of the authors (JH Chen and XQ Zhou). This study was approved by the Human Research Ethics Committee of Peking Union Medical College Hospital.
Seizure types were confirmed based on VEM and using the International League Against Epilepsy classification for epilepsies [18] , and classified as focal onset, generalized onset, or unknown onset [19] . Paroxysmal events were classified into one of the following three categories: epileptic seizure, when a concurrent ictal EEG pattern was demonstrated; psychogenic non-epileptic seizure (PNES), defined as an event mimicking an epileptic seizure but devoid of concurrent ictal or post-ictal EEG changes; other nonepileptic event, defined as a physiological event (cardiogenic or metabolic cause) or event related to another neurological disease (such as a sleep disorder, movement disorder, migraine, or transient ischemic attack) [20] .
The expected monitoring duration was decided before VEM according to seizure frequency and demand, which meant that the duration was usually at least one hour if the frequency was rare, 24 h or longer if frequency was daily or persistent, and prolonged until at least three paroxysmal events were captured if pre-surgery evaluation was demanded. For pre-surgery evaluation in patients on AEDs, the dose was reduced at a rate of one-third of the total daily dose every 24 h. Once targeted events were recorded three times, the patients resumed their usual AEDs regimen. the data were not normally distributed among groups. Logistic multivariable regression was also used. All statistical analyses were two-tailed and significance was set at p < 0.05. Statistical analyses were performed using SPSS Statistics 20.0 software (IBM, New York, USA).
Statistical analysis
Results
Patients characteristics and VEM findings
In total, 184 consecutive elderly inpatients were enrolled for VEM over the study period. Their mean age was 67.1 AE 6.1 years (range, 60-89 years), with 69 females (37.5%) and 115 males (62.5%). Mean VEM length was 20.4 AE 18.9 h (range, 1 h to 6 days) ( Table 1) . Referral sources of patients were epileptologists (82.6%) and general neurologists (17.4%). Up to 136 patients (73.9%) were admitted for diagnosis of paroxysmal events. There were 37 patients (20.1%) referred for classification of seizure types or epileptic syndromes and one patient (0.5%) for presurgical evaluation. Another 10 patients (5.4%) were admitted for evaluation for subclinical seizures or nonconvulsive status epilepticus. After discharge from hospital, 106 patients (57.6%) were followed up, with mean follow-up period being 22.5 AE 12.8 months (range, 4-54 months).
There were 134 patients (72.8%) finally confirmed epilepsy based on seizure semiology and characteristic EEGs, and 50 patients (27.2%) with final diagnosis not related with epilepsy. Fifty-three patients (39.6%) reported aura and 49 patients (36.6%) were found to show automatisms.
During VEM, 89 patients (48.4%) recorded paroxysmal events, including 58 epileptic seizures (31.5%) and 31 non-epileptic events (16.8%) ( Table 2 ). The median number of events recorded was five per patient (range, 0-175; mean, 26.8). Among all the patients, diagnostic yields of paroxysmal and non-epileptic events were 48.4% and 16.8%, respectively. There were 13 patients (7.1%) with PNES and 9 (4.9%) with sleep disorders. Among those with final diagnosis of epilepsy, diagnostic yield of epileptic events was 43.3%. Five patients (8.6%) had generalized onset seizures, and 53 patients (91.3%) had focal onset seizures, including 3 (5.2%) with focal to bilateral tonic-clonic seizures. There were 7 patients (3.8%) with both epileptic seizures and PNES. Twenty-nine patients (50%) had seizure onset in the temporal lobe, 19 patients (32.8%) in the frontal lobe, 3 patients (5.2%) in the occipital lobe, 1 patient (1.7%) in the parietal lobe, 2 patients (3.4%) with diffuse discharge and 4 patients (6.9%) had an uncertain origin. Two patients (3.4%) exhibited periodic lateralizing epileptiform discharges (PLEDS).
Before admission, 122 patients (66.3%) had routine EEGs, with 40 patients (23.8%) exhibiting interictal epileptiform discharges (IEDs). Further, IEDs during VEM were found in 71 patients (38.6%). Sixty-seven patients (52.3%) with epilepsy had IEDs. Brain MRI was available in 180 patients (97.8%). Seventy-four patients (41.1%) with epilepsy had abnormal brain MRI. Among them, VEEG findings in 33 patients (44.6%) correlated with MRI abnormalities (Table 3) .
Time to
first paroxysmal event Mean monitoring length in the positive subgroup with captured paroxysmal events was 25.7 AE 22.0 h, which was significantly longer than 15.5 AE 13.7 h in the negative subgroup without paroxysmal events captured (p = 0.001). Mean latency to first paroxysmal event during VEM was 6.6 AE 10.4 h (median, 3.8 h; range, 0.1-74.8 h). Median latency to first epileptic event was 3.8 h (mean, 6.4 AE 12.1 h; range, 0.1-74.8 h), while median latency to first non-epileptic event was 3.6 h (mean, 6.8 AE 6.1 h; range, 0.3-21.0
h).
There was no significant difference between median latency to first epileptic event or non-epileptic event (p = 0.15). Time to first event among genetic or unknown epilepsy, immune epilepsy, other symptomatic epilepsy, and non-epileptic groups, was not significantly different (H = 5.624, p = 0.131). The highest diagnostic yield of paroxysmal events occurred on the 24th hour of monitoring (Fig. 1) . All first non-epileptic events were captured during the first 24 h. All first epileptic events were detected during the first 4 days, with 98.9% of them recorded by the end of the 2nd day (Table 4) .
Relationship between paroxysmal events capture and length of monitoring
Binary logistic regression was used to identify factors related to paroxysmal events capture. The results showed that increased seizure incidence (p = 0.000, odd ratio [OR] = 0.075, 95% confidence 
Diagnostic yield in subgroups with different seizure frequency
All paroxysmal events in the confirmed epileptic patients with daily frequency were captured during the first 48 h. All paroxysmal events in the patients with persistent frequency were detected during the first 4 days. No positive case was found during the fifth to sixth day. No paroxysmal event was detected in the patients with rare frequency (Table 5 ).
In the subgroup with daily frequency, diagnostic yield of paroxysmal events was 75.5%, with epileptic seizures and nonepileptic seizures accounted for 48.9% and 26.6%, respectively. Diagnostic yield of paroxysmal events within 2 and 4 days, in the patients with persistent frequency, were 22.4% and 25.4%, respectively, with epileptic seizures and non-epileptic seizures accounted for 16.9% and 8.5% within 4 days.
Time since last paroxysmal event in relation to the timing VEM
Mean length since last paroxysmal event to end of VEM was 5.9 AE 9.5 h (median, 1.9 h; range, 0.2-47.5 h). Median length since last epileptic event to end was 1.9 h (mean, 6.5 AE 11.0 h; range, 0.2-47.5 h), and median length since last non-epileptic event to end was 1.5 h (mean, 4.8 AE 5.7 h; range, 0.3-21.0 h).
Discussion
This is the first study to examine the relationship between length of monitoring and paroxysmal events capture in elderly Chinese people. Prolonged VEEG is capable of capturing paroxysmal events, regardless of whether they are epileptic events or non-epileptic events, although its high cost hinders VEM in the elderly. We found that it was essential to set the expected monitoring duration as at least 24 h for both epileptic and non-epileptic events.
Various countries consider the onset of old age differently. The United Nations agreed on a cutoff of 60+ years. Similarly, in China, the age of 60 years is used as a definition of elderly, so we enrolled patients older than 60 years in our study.
Indeed, only 26% of epilepsy patients who were over 60 displayed IEDs [21] . Chochoi et al. [22] found that median time to occurrence of first epileptiform activity was 46.5 min, and concluded that VEM was clearly superior to standard EEG for detecting epileptiform activity in the elderly when non convulsive seizures were suspected. In our study, IEDs were found in 24% patients by routine EEG and 39% with VEM. Occurrence of the first non-epileptic event increased during the first 24 h of monitoring. Our results suggest that VEM is better than standard EEG, not only for detecting IEDs, but also when non-convulsive seizures are suspected.
Occurrence of paroxysmal events was related to seizure frequency and length of monitoring, but not with age at time of admission, gender, cause of seizure, IEDs, number or type of AEDs, or MRI abnormalities. With higher seizure frequency and longer monitoring duration, the more likely that VEM captured paroxysmal events. Time to first event captured during VEM was not influenced by the cause of seizures. Median time to first paroxysmal event was about 4 h, regardless of whether it was a non-epileptic or epileptic event. All non-epileptic events were captured within the first 24 h, with majority of first epileptic events recorded by the end of the 2nd day. Moreover, all first epileptic events were detected during the first 4 days. Our results are somewhat different from those previously reported. Foong and Seneviratne [23] found that median times to first epileptic seizure and PNES in adults was 19.7 and 23.4 h, respectively. Positivity of PNES in the first day was 52.8%, 28.3% in the second day, 11.3% in the third day, 5.7% in the fourth day, 1.9% in the fifth day, and none in the sixth day and later [23] . A small majority (53.7%) of eventpositive patients had their first event on the first day of monitoring [23] . By the end of the fifth day, 98% of all clinical events were captured and 99% of all positive cases diagnosed [23] . Hupalo et al. [24] reported that only 15% of epileptic seizures and 62% of PNES occurred within the first 24 h of VEM. Tolchin et al. [25] found that EEG duration predicted capture of a typical non-epileptic event with an OR of 2.7 for every additional day of study duration. Friedman and Hirsch [26] noted that it was common to require 3 or more days to record and diagnose the nature of paroxysmal episodes, while median time to first diagnostic event was 2 days. Possible explanations for this difference might be related with the different subjects studied. In our study, the subjects were elderly Chinese patients aged over 60 years, while they were Western adults aged 37 AE 11 years in Foong and Seneviratne's study [23] , 34.2 years in Hupalo et al.'s study [24] , and 40.5 years in Friedman and Hirsch's study [26] . In the study by Tolchin et al. [25] , diagnostic yield was performed by ambulatory EEG instead of VEEG. Mean monitoring duration in our study was about one day, which was shorter than 3.0 AE 1.7 days in Foong and Seneviratne's study [23] , 5 days in Hupalo et al.'s study [24] , and 5.5 days in Friedman and Hirsch's study [26] . Diagnostic yields were 48%, 52% [23] , 65% [24] , and 67% [24] for paroxysmal events, 43%, 27% [23] , 53% [24] , and 48% [26] for epileptic seizures, and 17%, 26% [23] , 12% [24] , and 19% [26] for non-epileptic events, compared with our study. One of the main factors that influenced diagnostic yield of paroxysmal events was indication of VEM. Because the referral sources of the patients in our study came from both epileptologists and general neurologists, we thought that strictly controlling the indication of VEM might increase diagnostic yield to a certain extent. The most important point about the difference between literature and our study lied in that no previous study had examined the diagnostic yield of paroxysmal events by VEM among subgroups with different seizure frequency, except ours. There should be different expected monitoring duration in the patients with different seizure frequency. From the economic and practical point of view, it seemed not necessary for the patients with daily or persistent frequency to be monitored as long as five days just like Foong and Seneviratne [23] having recommended. It was usually thought that more paroxysmal events would be recorded if VEM had been more prolonged and a patient with a daily frequency would only require a one day monitoring at most. While, we found that all positive cases in the patients with daily frequency were identified during the first 48 h, with 96% within 24 h. All positive cases in the patients with persistent frequency were determined during the first 4 days, with 92% within 24 h. Meanwhile, we also found cumulative positive cases increased consistently during the first 24 h, somewhat slowly on the 2nd and remained almost stable between the 3rd and 6th days. Considering most elders were admitted for diagnosis of paroxysmal events, and the cost of VEM increased with time, it was not economical to prolong monitoring length without a proportional benefit. Therefore, we speculated that 24 h of monitoring is acceptable for elders with non-epileptic seizures, especially when PNES is suspected, while 2 days (but no more than 4 days) when an epileptic seizure with daily or persistent frequency is considered, at least most of the time. It should be paid attention to that if patients have a seizure captured after medication discontinuation, they are usually kept at least a day in order to be resumed medication and observed, thus prolonging the monitoring duration by one day.
We regretted to find out that no patients with rare frequency were captured paroxysmal events, which implied that only one to two hours of monitoring would not be enough in these cases. What was the practical duration time for detecting paroxysmal events in these patients with rare frequency should still be further studied.
As one of the limitations, we acknowledged that only one patient was referred for pre-surgical evaluation, while 26% of the patients in our study had immune epilepsy, and were therefore not candidates for surgery. Further, among the patients with follow-up, only one patient had refractory focal epilepsy. Moreover, most of the enrolled patients had daily or persistent seizure frequency, which meant that they had severe epilepsy and the cohort skewed toward the high frequency events group. It still needs to testify whether our recommendations suitable for the patients with mild epilepsy, who might have delays of occurrence of epileptic events. The retrospective nature, lacking of a predetermined protocol and heterogeneity of AEDs treatment before VEM were also the limitations of our study. Anyway, performing a prospective cohort study is therefore warranted.
In conclusion, occurrence of paroxysmal events in VEM is associated with seizure frequency and length of monitoring. It may be practicable to monitor for 24 h when a non-epileptic seizure is suspected, with expected monitoring duration of 2 days when an epileptic seizure with daily or persistent frequency is considered, except for pre-surgical evaluations.
